The effect of exposome factors on the functions of filaggrin functions in atopic dermatitis
- Authors: Macharadze D.S.1
-
Affiliations:
- Peoples’ Friendship University of Russia
- Issue: Vol 19, No 2 (2022)
- Pages: 234-244
- Section: Reviews
- URL: https://rusalljournal.ru/raj/article/view/1511
- DOI: https://doi.org/10.36691/RJA1511
- ID: 1511
Cite item
Abstract
Atopic dermatitis is a heterogeneous inflammatory skin disease, which is affected by many internal (genetic) and external factors. The interaction between genetic and environmental factors is a complex dynamic process. These factors affect each other and can be interrelated.
This article discusses data on filaggrin and some exposome factors affecting it.
The term “exposome” refers to the impact of external factors on the biological environment of the body. The impact range is varied and includes chemicals, psychosocial and physical factors, as well as associated biological reactions that occur throughout human life.
The article examines the link between filaggrin mutations and genetic predisposition, as well as how the defects of the skin barrier, immunological imbalance, and a variety of stimuli have a potential impact. The mechanisms of action of various factors on filaggrin in atopic dermatitis are also considered. Furthermore, environmental factors can influence the expression of various genes and, as a result, create epigenetic changes in patients with atopic dermatitis.
The study of epigenetic changes is critical for understanding the molecular bases of this skin disease and optimizing treatment strategies.
Keywords
Full Text

About the authors
Dali Sh. Macharadze
Peoples’ Friendship University of Russia
Author for correspondence.
Email: dalim_a@mail.ru
ORCID iD: 0000-0001-5999-7085
SPIN-code: 2399-5783
MD, Dr. Sci (Med.)
Russian Federation, 6, Miklukho-Maklaya street, Moscow, 117198References
- Bieber T. Atopic dermatitis. N Engl J Med. 2008;358(14): 1483–1494. doi: 10.1056/NEJMra074081
- Abuabara K, You Y, Margolis DJ, et al. Genetic ancestry does not explain increased atopic dermatitis susceptibility or worse disease control among African American subjects in 2 large US cohorts. J Allergy Clin Immunol. 2020;145(1):192–198. doi: 10.1016/j.jaci.2019.06.044
- Flohr C, Mann J. New insights into the epidemiology of childhood atopic dermatitis. Allergy. 2014;69(1):3–16. doi: 10.1111/all.12270
- Hugg T, Ruotsalainen R, Jaakkola MS, et al. Comparison of allergic diseases, symptoms and respiratory infections between Finnish and Russian school children. Eur J Epidemiol. 2008;23(2):123–133. doi: 10.1007/s10654-007-9217-z
- Miller G, Jones D. The nature of nurture: refining the definition of the exposome. Toxicol Sci. 2014;137(1):1–2. doi: 10.1093/toxsci/kft251
- Odhiambo JA, Williams HC, Clayton TO, et al.; ISAAC Phase Three Study Group. Global variations in prevalence of eczema symptoms in children from ISAAC Phase Three. J Allergy Clin Immunol. 2009; 124(6):1251–1258. doi: 10.1016/j.jaci.2009.10.009
- Wegienka G, Zoratti E, Cole J. The role of the early-life environment in the development of allergic disease. Immunol Allergy Clin North Am. 2015;35(1):1–17. doi: 10.1016/j.iac.2014.09.002
- Edslev S, Agner T, Andersen P. Skin microbiome in atopic dermatitis. Acta Derm Venereol. 2020;100(12):adv00164. doi: 10.2340/00015555-3514
- Kong H, Oh J, Deming C, et al. Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis. Genome Res. 2012;22(5):850–859. doi: 10.1101/gr.131029.111
- Silverberg NB. A practical overview of pediatric atopic dermatitis, part 2: triggers and grading. Cutis. 2016;97(5):326–329.
- Celebi Sözener Z, Cevhertas L, Nadeau K, et al. Environmental factors in epithelial barrier dysfunction. J Allergy Clin Immunol. 2020;145(6):1517–1528. doi: 10.1016/j.jaci.2020.04.024
- Tamagawa-Mineoka R, Katoh N. Atopic dermatitis: identification and management of complicating factors. Int J Mol Sci. 2020; 21(8):2671. doi: 10.3390/ijms21082671
- Sroka-Tomaszewska J, Trzeciak M. Molecular mechanisms of atopic dermatitis pathogenesis. Int J Mol Sci. 2021;22(8):4130. doi: 10.3390/ijms22084130
- Katayama I, Aihara M, Ohya Y, et al.; Japanese Society of Allergology. Japanese guidelines for atopic dermatitis 2017. Allergol Int. 2017;66(2):230–247. doi: 10.1016/j.alit.2016.12.003
- Elmose C, Thomsen SF. Twin studies of atopic dermatitis: interpretations and applications in the filaggrin era. J Allergy (Cairo). 2015;2015:902359. doi: 10.1155/2015/902359
- Barnes KC. An update on the genetics of atopic dermatitis: scratching the surface in 2009. J Allergy Clin Immunol. 2010; 125(1):16–29. doi: 10.1016/j.jaci.2009.11.008
- Ring J, Alomar A, Bieber T, et al.; European Dermatology Forum (EDF); European Academy of Dermatology and Venereology (EADV); European Federation of Allergy (EFA); European Task Force on Atopic Dermatitis (ETFAD); European Society of Pediatric Dermatology (ESPD); Global Allergy and Asthma European Network (GA2LEN). Guidelines for treatment of atopic eczema (atopic dermatitis) part I. J Eur Acad Dermatol Venereol. 2012;26(8):1045–1060. doi: 10.1111/j.1468-3083.2012.04635
- Sigurdardottir ST, Jonasson K, Clausen M, et al. Prevalence and early-life risk factors of school-age allergic multimorbidity: The EuroPrevall-iFAAM birth cohort. Allergy. 2021;76(9):2855–2865. doi: 10.1111/all.14857
- Sandilands A, Sutherland C, Irvine AD, McLean WH. Filaggrin in the frontline: role in skin barrier function and disease. J Cell Sci. 2009; 122(Pt 9):1285–1294. doi: 10.1242/jcs.033969
- Drislane C, Irvine AD. The role of filaggrin in atopic dermatitis and allergic disease. Ann Allergy Asthma Immunol. 2020;124(1):36–43. doi: 10.1016/j.anai.2019.10.008
- Bisgaard H, Simpson A, Palmer CN, et al. Gene-environment interaction in the onset of eczema in infancy: filaggrin loss-of-function mutations enhanced by neonatal cat exposure. PLoS Med. 2008;5(6):e131. doi: 10.1371/journal.pmed.0050131
- Rupnik H, Rijavec M, Korosec P. Filaggrin loss-of-function mutations are not associated with atopic dermatitis that develops in late childhood or adulthood. Br J Dermatol. 2015;172(2):455–461. doi: 10.1111/bjd.13477
- Rodríguez E, Baurecht H, Herberich E, et al. Meta-analysis of filaggrin polymorphisms in eczema and asthma: robust risk factors in atopic disease. J Allergy Clin Immunol. 2009;123(6):1361–1370. doi: 10.1016/j.jaci.2009.03.036
- Morar N, Cookson WO, Harper JI, Moffatt MF. Filaggrin mutations in children with severe atopic dermatitis. J Invest Dermatol. 2007; 127(7):1667–1672. doi: 10.1038/sj.jid.5700739
- Soares P, Fidler K, Felton J, et al. Individuals with filaggrin-related eczema and asthma have increased long-term medication and hospital admission costs. Br J Dermatol. 2018;179(3):717–723. doi: 10.1111/bjd.16720
- Ballardini N, Kull I, Söderhäll C, et al. Eczema severity in preadolescent children and its relation to sex, filaggrin mutations, asthma, rhinitis, aggravating factors and topical treatment: a report from the BAMSE birth cohort. Br J Dermatol. 2013;168(3):588–594. doi: 10.1111/bjd.12196
- Engebretsen K, Kezic S, Jakasa I, et al. Effect of atopic skin stressors on natural moisturizing factors and cytokines in healthy adult epidermis. Br J Dermatol. 2018;179(3):679–688. doi: 10.1111/bjd.16487
- Danby S, Brown K, Wigley A, et al. The effect of water hardness on surfactant deposition after washing and subsequent skin irritation in atopic dermatitis patients and healthy control subjects. J Invest Dermatol. 2018;138(1):68–77. doi: 10.1016/j.jid.2017.08.037
- Clausen M, Edslev S, Andersen P, et al. Staphylococcus aureus colonization in atopic eczema and its association with filaggrin gene mutations. Br J Dermatol. 2017;177(5):1394–1400. doi: 10.1111/bjd.15470
- Nakatsuji T, Chen TH, Two AM, et al. Staphylococcus aureus exploits epidermal barrier defects in atopic dermatitis to trigger cytokine expression. J Invest Dermatol. 2016;136(11):2192–2200. doi: 10.1111/bjd.15470
- Nakamura Y, Oscherwitz J, Cease KB, et al. Staphylococcus delta-toxin induces allergic skin disease by activating mast cells. Nature. 2013;503(7476):397–401. doi: 10.1038/nature12655
- Miajlovic H, Fallon PG, Irvine AD, Foster TJ. Effect of filaggrin breakdown products on growth of and protein expression by Staphylococcus aureus. J Allergy Clin Immunol. 2010;126(6): 1184–1190. doi: 10.1016/j.jaci.2010.09.015
- Khayyira A, Rosdina A, Irianti M, Malik A. Simultaneous profiling and cultivation of the skin microbiome of healthy young adult skin for the development of therapeutic agents. Heliyon. 2020;6(4):e03700. doi: 10.1016/j.jaci.2010.09.015
- Illi S, von Mutius E, Lau S, et al.; Multicenter Allergy Study Group. The natural course of atopic dermatitis from birth to age 7 years and the association with asthma. J Allergy Clin Immunol. 2004;113(5):925–931. doi: 10.1016/j.jaci.2004.01.778
- Smieszek SP, Welsh S, Xiao C, et al. Correlation of age-of-onset of Atopic Dermatitis with Filaggrin loss-of-function variant status. Sci Rep. 2020;10(1):2721. doi: 10.1038/s41598-020-59627-7
- Bin L, Leung D. Genetic and epigenetic studies of atopic dermatitis. Allergy Asthma Clin Immunol. 2016;12:52. doi: 10.1186/s13223-016-0158-5
- Nedoszytko B, Reszka E, Gutowska-Owsiak D, et al. Genetic and epigenetic aspects of atopic dermatitis. Int J Mol Sci. 2020;21(18):6484. doi: 10.3390/ijms21186484
- Samuelov L, Sarig O, Harmon RM, et al. Desmoglein 1 deficiency results in severe dermatitis, multiple allergies and metabolic wasting. Nat Genet. 2013;45(10):1244–1248. doi: 10.1038/ng.2739
- Thijs JL, Strickland I, Bruijnzeel-Koomen C, et al. Serum biomarker profiles suggest that atopic dermatitis is a systemic disease. J Allergy Clin Immunol. 2018;141(4):1523–1526. doi: 10.1016/j.jaci.2017.12.991
- Stefanovic N, Flohr C, Irvine AD. The exposome in atopic dermatitis. Allergy. 2020;75(1):63–74. doi: 10.1111/all.13946
- Yu X, Wang M, Li L, et al. MicroRNAs in atopic dermatitis: A systematic review. J Cell Mol Med. 2020;24(11):5966–5972. doi: 10.1111/jcm
- Genuneit J, Seibold AM, Apfelbacher CJ, et al. Overview of systematic reviews in allergy epidemiology. Allergy. 2017;72(6): 849–856. doi: 10.1111/all.13123
- Schmidt AD, de Strong C. Current understanding of epigenetics in atopic dermatitis. Exp Dermatol. 2021;30(8):1150–1155. doi: 10.1111/exd.14392
Supplementary files
There are no supplementary files to display.
